whats the company worth today

My view

44 million in the bank

250 million for the development of drug in America

180 million share on registry

so

294 million dollars divided by 180 million shares multiplied by 74 percent

assuming the nasdaq listing occurs

$1.20

does not take into account the pipe line of drugs

does not take into account the relenza top up

does not take into account the flu drug sales in japan


this is only a very simplified view and an opinion of mine which should not be used for investment advice